Integra Lifesciences Holdings Corp (STU:IL3)
€ 23.8 0.8 (3.48%) Market Cap: 1.83 Bil Enterprise Value: 3.43 Bil PE Ratio: 0 PB Ratio: 1.29 GF Score: 71/100

Integra Lifesciences Holdings Corp at Jefferies Healthcare Conference Transcript

Jun 05, 2019 / 08:30PM GMT
Release Date Price: €41.95 (+2.02%)
Rajbir Singh Denhoy
Jefferies LLC, Research Division - MD, Equity Research & Senior Equity Research Analyst

Thanks, everyone, for joining us here at the end of the second day here at the Jefferies Healthcare Conference. Again, I'm Raj Denhoy with the medical device team. Up next, we have Integra LifeSciences, and we're doing a fireside chat. So if anybody has any questions, please feel free to chime in.

From the company, we have Sravan Emany, the company's Head of Strategy; as well as Peter Arduini, the company's CEO. And so again, we're just going to jump right into questions, and please feel free to ask any if you have some.

Questions & Answers

Rajbir Singh Denhoy
Jefferies LLC, Research Division - MD, Equity Research & Senior Equity Research Analyst

Pete, maybe I could just start with -- I think the question that probably comes up the most is the company's guidance not only over the short term, but also over the next several years for accelerating growth at the company. The first part of this year, it's expected to be a little

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot